Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID.

Honore, Patrick M; Redant, Sebastien; Preseau, Thierry; Cismas, Bogdan Vasile; Kaefer, Keitiane; Barreto Gutierrez, Leonel; Anane, Sami; Attou, Rachid; Gallerani, Andrea; De Bels, David

Honore, Patrick M; Redant, Sebastien; Preseau, Thierry; Cismas, Bogdan Vasile; Kaefer, Keitiane; Barreto Gutierrez, Leonel; Anane, Sami; Attou, Rachid; Gallerani, Andrea; De Bels, David.

Honore PM; ICU Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Patrick.Honore@CHU-Brugmann.be.
Redant S; ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital, Faculty of Medicine,, ULB University, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium. Patrick.Honore@CHU-Brugmann.be.
Preseau T; ICU Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
Cismas BV; ED Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
Kaefer K; ED Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Crit Care ; 25(1): 425, 2021 12 14.

Article in English | MEDLINE | ID: covidwho-1582031

Subject(s)

COVID-19; Pulmonary Embolism; Respiratory Distress Syndrome; Humans; Proteoglycans; SARS-CoV-2

Keywords

ARDS severity; Endocan; Pulmonary embolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / Respiratory Distress Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Crit Care Year: 2021 Document Type: Article Affiliation country: S13054-021-03850-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google